Maturity Onset Diabetes of the Young Masquerading as New Onset Diabetes Mellitus Type 1
نویسندگان
چکیده
منابع مشابه
[Diabetes mellitus onset in young patient: type 1 diabetes?].
mptomatic diabetes as a manifestation of another underng condition is uncommon, and usually due to the use drugs with hyperglycemic potential or to neoplastic prosses in the pancreatic area. Among drugs, special mention uld be made of high-dose steroids and, more recently d in young patients, atypical neuroleptics.1 The onset of rdinal symptoms of diabetes mellitus (DM) in a patient der 40 year...
متن کاملEnvironmental Factors before the Onset of Type 1 Diabetes Mellitus: A Case-Control Study
Objective: The role of environmental factors in the development of type1 diabetes mellitus (T1D) is inconclusive. This study aimed to investigate the associations between selected environmental factors and T1D. Materials and Methods: This group matched case-control study included diabetic and healthy subjects younger than 19 years old in 2017. Cases were diabetic subjects diagnosed before the ...
متن کاملMaturity onset diabetes of the young--review.
Maturity onset diabetes of the young (MODY) is characterized by a primary defect in insulin secretion and hyperglycemia, nonketotic disease, monogenic autosomal dominant mode of inheritance, age at onset less than 25 years, and lack of auto-antibodies. It accounts for 2-5% of all cases of non-type 1 diabetes. The diagnosis may be made by careful clinical evaluation, but exact subtyping is possi...
متن کاملEarly maturity onset diabetes mellitus presenting as episodes of hypoglycaemia.
Diabetes mellitus is a genetically determined disorder of metabolism which in it's fully developed clinial expression is characterized by fasting hyperglycaemia. In early maturity onset diabetes the most common abnormality is delayed secretion of insulin following a glycaemic stimulus which may then be followed by an exaggerated response (Seltzer et al., 1967). This disturbance of insulin in ea...
متن کاملMaturity-Onset Diabetes
Dr. Felig is an Established Investigator of the American Diabetes Association. Dr. Soman is a recipient of a Clinical Investigator Award (AM-00356) from the National Institutes of Health and of a Research and Development Award from the American Diabetes Association. Received for publication 20 July 1978 and in revised form 24 November 1978. Insulin binding to monocytes and insulin action as det...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Endocrine Society
سال: 2021
ISSN: 2472-1972
DOI: 10.1210/jendso/bvab048.797